Cargando…

Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma

OBJECTIVE: To identify the key drugs of Yangyin Fuzheng Jiedu prescription (YFJP) and investigate their therapeutic effects against hepatocellular carcinoma (HCC) and the potential mechanism using network pharmacology. METHODS: The H22 tumor‐bearing mouse model was established. Thirty male BALB/c mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Yuqing, Yan, Fengna, Wang, Xinhui, Yu, Lihua, Yan, Huiwen, Pu, Qing, Li, Weihong, Yang, Zhiyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939140/ https://www.ncbi.nlm.nih.gov/pubmed/36043445 http://dx.doi.org/10.1002/cam4.5064

Ejemplares similares

Molecular targets of Yangyin Fuzheng Jiedu Prescription in the treatment of hepatocellular carcinoma based on network pharmacology analysis
por: Yan, Fengna, et al.
Publicado: (2020)

Network Pharmacology Interpretation of Fuzheng–Jiedu Decoction against Colorectal Cancer
por: Shi, Hongshuo, et al.
Publicado: (2021)

Yangyin Fuzheng Decoction enhances anti-tumor efficacy of cisplatin on lung cancer
por: Wei, Dongmei, et al.
Publicado: (2018)

Study on Mechanism of Yiqi Yangyin Jiedu Recipe Inhibiting Triple Negative Breast Cancer Growth: A Network Pharmacology and In Vitro Verification
por: Sun, Xin, et al.
Publicado: (2022)

Establishment of Nomogram Model for Minimally Invasive Treatment of Small Hepatocellular Carcinoma Based on CD8(+)T Cell Counts
por: Pu, Qing, et al.
Publicado: (2022)

Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy
por: Yu, Lihua, et al.
Publicado: (2022)

Immunomodulatory Effect of Traditional Chinese Medicine Combined with Systemic Therapy on Patients with Liver Cancer: A Systemic Review and Network Meta-analysis
por: Pu, Qing, et al.
Publicado: (2022)

Efficacy of Yiqi Yangyin Jiedu decoction in postoperative patients with thyroid cancer: A protocol for systematic review and meta-analysis
por: Li, Qiao, et al.
Publicado: (2022)

Antiviral Therapy Reduces Mortality in Hepatocellular Carcinoma Patients with Low-Level Hepatitis B Viremia
por: Wang, Xinhui, et al.
Publicado: (2021)

In Vitro Antibacterial Experiment of Fuzheng Jiedu Huayu Decoction Against Multidrug-Resistant Pseudomonas aeruginosa
por: Xu, Hongri, et al.
Publicado: (2020)

Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma
por: Wang, Peng, et al.
Publicado: (2023)

A Nomogram Prognostic Model for Advanced Hepatocellular Carcinoma Based on the Interaction Between CD8(+)T Cell Counts and Age
por: Wu, Yuan, et al.
Publicado: (2023)

A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy
por: Zhou, Dongdong, et al.
Publicado: (2021)

Spectrum-Effect Relationship between HPLC Fingerprints and Antioxidant Activity of Yangyin Tongnao Prescription
por: Yu, Li, et al.
Publicado: (2021)

Investigating the cardioprotective effects of Fuzheng Yangxin recipe based on network pharmacology and experimental evaluation
por: Wang, Anzhu, et al.
Publicado: (2022)

A network pharmacology and bioinformatics exploration of the possible molecular mechanisms of Fuzheng Xiaoliu Granule for the treatment of hepatocellular carcinoma
por: Fan, Tianyu, et al.
Publicado: (2023)

Study on the Mechanism of Huanglian Jiedu Decoction in Treating Dyslipidemia Based on Network Pharmacology
por: Gong, Zhaohui, et al.
Publicado: (2022)

Study on Intervention Mechanism of Yiqi Huayu Jiedu Decoction on ARDS Based on Network Pharmacology
por: Liang, Xu, et al.
Publicado: (2020)

TIGIT(+) TIM-3(+) NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related hepatocellular carcinoma
por: Yu, Lihua, et al.
Publicado: (2021)

Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of Huanglian Jiedu Decoction in Treating Atherosclerosis
por: Liang, Jiahua, et al.
Publicado: (2021)

Mechanistic Insights of Qingre Jiedu Recipe Based on Network Pharmacology Approach against Heart Failure
por: Li, Xuan, et al.
Publicado: (2022)

Based on the Network Pharmacology to Investigate the Mechanism of Qingjie Fuzheng Granules against Colorectal Cancer
por: Fang, Yi, et al.
Publicado: (2022)

Exploration of Fuzheng Yugan Mixture on COVID-19 based on network pharmacology and molecular docking
por: Jiang, Xinyu, et al.
Publicado: (2023)

The survival strength of younger patients in BCLC stage 0-B of hepatocellular carcinoma: basing on competing risk model
por: Yan, Huiwen, et al.
Publicado: (2022)

Pharmacological mechanisms of Fuzheng Huayu formula for Aristolochic acid I–induced kidney fibrosis through network pharmacology
por: Wang, Fan, et al.
Publicado: (2022)

Integrating Network Pharmacology and Experimental Validation to Elucidate the Mechanism of Yiqi Yangyin Decoction in Suppressing Non-Small-Cell Lung Cancer
por: Jiao, Pengfei, et al.
Publicado: (2023)

Dynamic Nomogram for Predicting Macrovascular Invasion of Patients with Unresectable Hepatocellular Carcinoma after Transarterial Chemoembolization
por: Yan, Huiwen, et al.
Publicado: (2022)

Decoding the Mechanism of Huanglian Jiedu Decoction in Treating Pneumonia Based on Network Pharmacology and Molecular Docking
por: Li, Xianhai, et al.
Publicado: (2021)

Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools
por: Xiong, Haijun, et al.
Publicado: (2020)

Molecular mechanisms of Huanglian jiedu decoction on ulcerative colitis based on network pharmacology and molecular docking
por: Yang, Jing, et al.
Publicado: (2022)

Molecular Mechanism of the Effect of Huanglian Jiedu Decoction on Type 2 Diabetes Mellitus Based on Network Pharmacology and Molecular Docking
por: Yin, Bei, et al.
Publicado: (2020)

Synergisic effect of APRIL knockdown and Jiedu Xiaozheng Yin, a Chinese medicinal recipe, on the inhibition of hepatocellular carcinoma cell proliferation
por: Liu, Zhizhen, et al.
Publicado: (2017)

The Yiqi and Yangyin Formula ameliorates injury to the hematopoietic system induced by total body irradiation
por: Zhang, Junling, et al.
Publicado: (2017)

Exploring the Potential Mechanism of Xiaokui Jiedu Decoction for Ulcerative Colitis Based on Network Pharmacology and Molecular Docking
por: Wang, Bin, et al.
Publicado: (2021)

Chinese Herbal Medicine (Yiqi-Yangyin-Jiedu Decoction) Combined With Osimertinib as First-Line Treatment in EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer (CATLA-2): A Study Protocol for a Double-Blind Randomized Controlled Trial
por: Yao, Jialin, et al.
Publicado: (2022)

The Active Components of Fuzheng Huayu Formula and Their Potential Mechanism of Action in Inhibiting the Hepatic Stellate Cells Viability – A Network Pharmacology and Transcriptomics Approach
por: Xing, Xinrui, et al.
Publicado: (2018)

Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology
por: Chen, Xiao, et al.
Publicado: (2020)

Effect of sitagliptin combined with Yiqi yangyin huoxue decoction on clinical efficacy and hemorheology in early diabetic nephropathy
por: Ling, Jun, et al.
Publicado: (2023)

Yiqi Yangyin Huoxue Method in Treating Diabetic Retinopathy: A Systematic Review and Meta-Analysis
por: Ou, Chen, et al.
Publicado: (2019)

Constructing the Logical Regression Model to Predict the Target of Jianpi Jiedu Decoction in the Treatment of Hepatocellular Carcinoma
por: Zhang, Rongjie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6q0guahh6njlb1jarkg0q4q03d